---
reference_id: "PMID:34133854"
title: Treatment of Multisystem Inflammatory Syndrome in Children.
authors:
- McArdle AJ
- Vito O
- Patel H
- Seaby EG
- Shah P
- Wilson C
- Broderick C
- Nijman R
- Tremoulet AH
- Munblit D
- Ulloa-Gutierrez R
- Carter MJ
- De T
- Hoggart C
- Whittaker E
- Herberg JA
- Kaforou M
- Cunnington AJ
- Levin M
- BATS Consortium
journal: N Engl J Med
year: '2021'
doi: 10.1056/NEJMoa2102968
content_type: abstract_only
---

# Treatment of Multisystem Inflammatory Syndrome in Children.
**Authors:** McArdle AJ, Vito O, Patel H, Seaby EG, Shah P, Wilson C, Broderick C, Nijman R, Tremoulet AH, Munblit D, Ulloa-Gutierrez R, Carter MJ, De T, Hoggart C, Whittaker E, Herberg JA, Kaforou M, Cunnington AJ, Levin M, BATS Consortium
**Journal:** N Engl J Med (2021)
**DOI:** [10.1056/NEJMoa2102968](https://doi.org/10.1056/NEJMoa2102968)

## Content

1. N Engl J Med. 2021 Jul 1;385(1):11-22. doi: 10.1056/NEJMoa2102968. Epub 2021
Jun  16.

Treatment of Multisystem Inflammatory Syndrome in Children.

McArdle AJ(1), Vito O(1), Patel H(1), Seaby EG(1), Shah P(1), Wilson C(1), 
Broderick C(1), Nijman R(1), Tremoulet AH(1), Munblit D(1), Ulloa-Gutierrez 
R(1), Carter MJ(1), De T(1), Hoggart C(1), Whittaker E(1), Herberg JA(1), 
Kaforou M(1), Cunnington AJ(1), Levin M(1); BATS Consortium.

Collaborators: Levin M, Broderick C, Cunnington A, Herberg J, Kaforou M, McArdle 
A, Nijman R, Patel H, Seaby E, Shah P, Vito O, Whittaker E, Wilson C, Hoggart C, 
De T, Munblit D, Tremoulet A, Ulloa-Gutierrez R, Agrimbau Vázquez J, Carmona R, 
Pérez L, Rubiños M, Veliz N, Yori S, Holter W, Krainz M, Ulreich R, Zurl C, 
Haerynck F, Hoste L, Leal IA, Araujo da Silva AR, Araujo E Silva AE, Barchik A, 
Barreiro STA, Cochrane N, Teixeira CH, Araujo JM, Paternina-de la Ossa RA, Souza 
Vieira C, Dimitrova A, Ganeva M, Stefanov S, Telcharova-Mihaylovska A, Biggs CM, 
Scuccimarri R, Withington D, Ampuero C, Aravena J, Bustos B R, Casanova D, 
Cruces P, Diaz F, García-Salum T, Godoy L, Medina RA, Valenzuela Galaz G, 
Avila-Aguero ML, Brenes-Chacón H, Ivankovich-Escoto G, Yock-Corrales A, Badib A, 
Badreldin K, Elkhashab Y, Heshmat H, Heinonen S, Angoulvant F, Belot A, Ouldali 
N, Beske F, Heep A, Masjosthusmann K, Reiter K, van den Heuvel I, von Both U, 
Agrafiotou A, Antachopoulos C, Eleftheriou I, Farmaki E, Fotis L, Kafetzis D, 
Lampidi S, Liakopoulou T, Maritsi D, Michailidou E, Milioudi M, Mparmpounaki I, 
Papadimitriou E, Papaevangelou V, Roilides E, Tsiatsiou O, Tsolas G, Tsolia M, 
Vantsi P, Banegas Pineda LY, Borjas Aguilar KL, Cantillano Quintero EM, Ip P, 
Kwan MYW, Kwok J, Lau YL, To K, Wong JSC, David M, Farkas D, Kalcakosz S, 
Szekeres K, Zsigmond B, Aslam N, Andreozzi L, Bianco F, Bucciarelli V, Buonsenso 
D, Cimaz R, D'Argenio P, Dellepiane RM, Fabi M, Mastrolia MV, Mauro A, Mazza A, 
Romani L, Simonini G, Tipo V, Valentini P, Verdoni L, Reel B, Pace D, Torpiano 
P, Fonseca Flores M, García Domínguez M, Vargas ALG, Lopez Hernández L, Mota 
Figueroa RP, Pérez Gaxiola G, Valadez J, Klevberg S, Knudsen PK, Måseide PH, 
Carrera JM, Castaño G E, Daza Timana CA, De Leon T, Estripeaut D, Levy Z J, 
Norero X, Record J, Rojas-Bonilla M, Iramain R, Hernandez R, Huamán G, Munaico 
M, Peralta C, Seminario D, Zapata Yarlequé EH, Gadzinska J, Mandziuk J, 
Okarska-Napierała M, Alacheva ZA, Alexeeva E, Ananin PV, Antsupova M, Bakradze 
MD, Bobkova P, Borzakova S, Chashchina IL, Fisenko AP, Gautier MS, Glazyrina A, 
Kondrikova E, Korobyants E, Korsunskiy AA, Kovygina K, Krasnaya E, Kurbanova S, 
Kurdup MK, Mamutova AV, Mazankova L, Mitushin IL, Nargizyan A, Orlova YO, 
Osmanov IM, Polyakova AS, Romanova O, Samitova E, Sologub A, Spiridonova E, 
Tepaev RF, Tkacheva AA, Yusupova V, Zholobova E, Grasa CD, Lopez Segura N, 
Martinon-Torres F, Melendo S, Mendez Echevarria A, Mesa Guzmán JM, Palacios 
Argueta JR, Rivero-Calle I, Rivière J, Rodríguez-González M, Rojo P, Sanchez 
Manubens J, Soler-Palacin P, Soriano-Arandes A, Tagarro A, Villaverde S, Altman 
M, Brodin P, Horne A, Palmblad K, Brotschi B, Meyer Sauteur P, Pachlopnik Schmid 
J, Prader S, Relly C, Schlapbach LJ, Seiler M, Trück J, Ketharanathan N, Vermont 
C, Özkan EA, Erdeniz EH, Borisova G, Boychenko L, Diudenko N, Kasiyan O, 
Katerynych K, Melnyk K, Miagka N, Teslenko M, Trykosh M, Volokha A, Akomolafe T, 
Al-Abadi E, Alders N, Avram P, Bamford A, Banks M, Basu Roy R, Beattie T, Boleti 
O, Broad J, Carrol ED, Carter M, Chandran A, Cooper H, Davies P, Emonts M, Evans 
C, Fidler K, Foster C, Gong C, Gongrun B, Gonzalez C, Grandjean L, Grant K, 
Hacohen Y, Hall J, Hassell J, Hesketh C, Hewlett J, Hnieno A, Holt-Davis H, 
Hossain A, Hudson LD, Johnson M, Johnson S, Jyothish D, Kampmann B, Kavirayani 
A, Kelly D, Kucera F, Langer D, Lillie J, Longbottom K, Lyall H, Mackdermott N, 
Maltby S, Mclelland T, McMahon AM, Miller D, Morrison Z, Moshal K, Muller J, 
Myttaraki E, Nadel S, Osaghae D, Osman F, Ostrzewska A, Panthula M, Papachatzi 
E, Papadopoulou C, Penner J, Polandi S, Prendergast AJ, Ramnarayan P, Rhys-Evans 
S, Riordan A, Rodrigues CMC, Romaine S, Seddon J, Shingadia D, Srivastava A, 
Struik S, Taylor A, Taylor A, Taylor A, Tran S, Tudor-Williams G, van der Velden 
F, Ventilacion L, Wellman PA, Yanney MP, Yeung S, Badheka A, Badran S, Bailey 
DM, Burch AK, Burns JC, Cichon C, Cirks B, Dallman MD, Delany DR, Fairchok M, 
Friedman S, Geracht J, Langs-Barlow A, Mann K, Padhye A, Quade A, Ramirez KA, 
Rockett J, Sayed IA, Shahin AA, Umaru S, Widener R, Mujuru HA, Kandawasvika G.

Author information:
(1)From the Department of Infectious Disease, Section of Pediatric Infectious 
Disease (A.J.M., O.V., H.P., E.G.S., P.S., C.W., C.B., R.N., T.D., E.W., J.A.H., 
M.K., A.J.C., M.L.), and the Inflammation, Repair, and Development Section, 
National Heart and Lung Institute, Faculty of Medicine (D.M.), Imperial College 
London, the Department of Pediatrics, Imperial College Healthcare NHS Trust 
(R.N., E.W., J.A.H., A.J.C., M.L.), and the Department of Women and Children's 
Health, School of Life Course Sciences, King's College London, St. Thomas' 
Hospital (M.J.C.), London, and the Genomic Informatics Group, University of 
Southampton, Southampton (E.G.S.) - all in the United Kingdom; the Translational 
Genomics Group, Broad Institute of MIT and Harvard, Cambridge, MA (E.G.S.); the 
Department of Pediatrics, University of California, San Diego, and Rady 
Children's Hospital, San Diego (A.H.T.); the Department of Pediatrics and 
Pediatric Infectious Diseases, Sechenov University, Moscow (D.M.); Servicio de 
Infectología, Hospital Nacional de Niños Dr. Carlos Sáenz Herrera, Centro de 
Ciencias Médicas, Caja Costarricense de Seguro Social, San José, Costa Rica 
(R.U.-G.); and the Department of Genetics and Genomic Sciences, Icahn School of 
Medicine at Mount Sinai, New York (C.H.).

Comment in
    N Engl J Med. 2021 Jul 1;385(1):74-75. doi: 10.1056/NEJMe2108276.
    N Engl J Med. 2021 Sep 23;385(13):e42. doi: 10.1056/NEJMc2111096.
    N Engl J Med. 2021 Sep 23;385(13):e42. doi: 10.1056/NEJMc2111096.

BACKGROUND: Evidence is urgently needed to support treatment decisions for 
children with multisystem inflammatory syndrome (MIS-C) associated with severe 
acute respiratory syndrome coronavirus 2.
METHODS: We performed an international observational cohort study of clinical 
and outcome data regarding suspected MIS-C that had been uploaded by physicians 
onto a Web-based database. We used inverse-probability weighting and generalized 
linear models to evaluate intravenous immune globulin (IVIG) as a reference, as 
compared with IVIG plus glucocorticoids and glucocorticoids alone. There were 
two primary outcomes: the first was a composite of inotropic support or 
mechanical ventilation by day 2 or later or death; the second was a reduction in 
disease severity on an ordinal scale by day 2. Secondary outcomes included 
treatment escalation and the time until a reduction in organ failure and 
inflammation.
RESULTS: Data were available regarding the course of treatment for 614 children 
from 32 countries from June 2020 through February 2021; 490 met the World Health 
Organization criteria for MIS-C. Of the 614 children with suspected MIS-C, 246 
received primary treatment with IVIG alone, 208 with IVIG plus glucocorticoids, 
and 99 with glucocorticoids alone; 22 children received other treatment 
combinations, including biologic agents, and 39 received no immunomodulatory 
therapy. Receipt of inotropic or ventilatory support or death occurred in 56 
patients who received IVIG plus glucocorticoids (adjusted odds ratio for the 
comparison with IVIG alone, 0.77; 95% confidence interval [CI], 0.33 to 1.82) 
and in 17 patients who received glucocorticoids alone (adjusted odds ratio, 
0.54; 95% CI, 0.22 to 1.33). The adjusted odds ratios for a reduction in disease 
severity were similar in the two groups, as compared with IVIG alone (0.90 for 
IVIG plus glucocorticoids and 0.93 for glucocorticoids alone). The time until a 
reduction in disease severity was similar in the three groups.
CONCLUSIONS: We found no evidence that recovery from MIS-C differed after 
primary treatment with IVIG alone, IVIG plus glucocorticoids, or glucocorticoids 
alone, although significant differences may emerge as more data accrue. (Funded 
by the European Union's Horizon 2020 Program and others; BATS ISRCTN number, 
ISRCTN69546370.).

Copyright © 2021 Massachusetts Medical Society.

DOI: 10.1056/NEJMoa2102968
PMCID: PMC8220965
PMID: 34133854 [Indexed for MEDLINE]